Advancement of antiangiogenic and vascular disrupting agents combined with radiation.

作者: Deborah Citrin , Kevin Camphausen

DOI: 10.1007/978-0-387-36744-6_8

关键词:

摘要: Technologic advances in therapeutic radiation targeting and delivery have led to improved tumor cure reduced normal tissue toxicity. While further progress these areas is probable, it evident that significant improvements the ratio may result from alterations biologic response of tumors tissues ionizing radiation. By selectively enhancing lethality by unique aspects tumors, local control be achieved without increasing One area ongoing research has focused on identifying potential targets specific manipulated enhance These agents are diverse their origin, action, efficacy. Agents target established or proliferating vasculature a one class such agents. can classified as antiangiogenic agents, primarily inhibit formation new blood vessels, vascular disrupting (VDAs), vasculature. For purpose this chapter, VDAs will discussed separately, however, several compounds been found exhibit both properties.

参考文章(78)
Patrizia Mancuso, Angelica Calleri, Cristina Cassi, Alberto Gobbi, Manuela Capillo, Giancarlo Pruneri, Giovanni Martinelli, Francesco Bertolini, Circulating endothelial cells as a novel marker of angiogenesis. Advances in Experimental Medicine and Biology. ,vol. 522, pp. 83- 97 ,(2003) , 10.1007/978-1-4615-0169-5_9
Michael I. Koukourakis, Alexandra Giatromanolaki, Efthimios Sivridis, Kevin C. Gatter, Konstantinos Simopoulos, George Pissakas, Adrian L. Harris, Squamous cell head and neck cancer: evidence of angiogenic regeneration during radiotherapy. Anticancer Research. ,vol. 21, pp. 4301- 4309 ,(2001)
David J. Chaplin, Michael R. L. Stratford, Borivoj Vojnovic, Rosalind J. Locke, Gillian M. Tozer, Francesca Lee, Susan M. Galbraith, Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivo. Anticancer Research. ,vol. 21, pp. 93- 102 ,(2001)
Q. S. Ng, D. Carnell, J. Milner, K. Meer, M. I. Saunders, P. J. Hoskin, Phase Ib trial of Combretastatin A4 Phosphate (CA4P) in combination with radiotherapy (RT): Initial clinical results Journal of Clinical Oncology. ,vol. 23, pp. 3117- 3117 ,(2005) , 10.1200/JCO.2005.23.16_SUPPL.3117
M. Bewick, M. Conlon, H. Lee, A. M. Parissenti, L. Zhang, S. Glück, R. M. Lafrenie, Evaluation of sICAM-1, sVCAM-1, and sE-Selectin levels in patients with metastatic breast cancer receiving high-dose chemotherapy. Stem Cells and Development. ,vol. 13, pp. 281- 294 ,(2004) , 10.1089/154732804323099217
Judith A. Stanley, William U. Shipley, G. Gordon Steel, Tumor size dependency in the radiation response of the Lewis lung carcinoma. Cancer Research. ,vol. 35, pp. 2488- 2493 ,(1975)
Barbara Imberti, Patrizia Borsotti, Raffaella Giavazzi, Giulia Taraboletti, Maura Poli, Michele Martinelli, Gianluca Micheletti, Vascular-targeting activity of ZD6126, a novel tubulin-binding agent. Cancer Research. ,vol. 63, pp. 1534- 1537 ,(2003)
Peter Carmeliet, Rakesh K. Jain, Angiogenesis in cancer and other diseases Nature. ,vol. 407, pp. 249- 257 ,(2000) , 10.1038/35025220
Thomas Boehm, Judah Folkman, Timothy Browder, Michael S. O'Reilly, Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature. ,vol. 390, pp. 404- 407 ,(1997) , 10.1038/37126